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In order to accurately measure changes in cardiac electrical threshold, as 
evoked by pharmacological or physiological interventions, it is necessary to 
define clearly the term threshold and the method of measuring it. Electrical 
threshold at any given time is the minimum electrical impulse necessary to stimu- 
late the heart for the specific electrical system being used at that time. Deter- 
minants of threshold for any pacemaker system are many, and can be thought of 
as comprising extrinsic and intrinsic factors. Extrinsic factors, which are deter- 
mined by engineering design, include electrode composition, electrode surface 
area, electrode impedance, and the waveform, voltage, current, and duration of 
the stimulus. Since the biological impedance of the heart and other body tissues 
is nonlinear, threshold may vary with different stimulus-voltage or current levels, 
and changes in stimulus duration also produce changes in threshold. Intrinsic 
threshold factors, more the domain of the biological scientist, include the position 
of the electrode on or inside the heart, the electrochemical interface between 
the electrode and surrounding tissue, and the intrinsic excitability of the tissue. 
The electrode-tissue interface is partly extrinsic and partly intrinsic, but prob- 
ably cannot be altered by external interventions after complete implantation of a 
pacemaker system. Similarly, with the exception of repositioning a catheter, 
electrode position is also fixed after permanent implantation. We are therefore 
usually left with only one factor that can be altered after permanent implantation 
of a pacemaker system, i.e., excitability of cardiac tissue. 
Exit block is a term that we believe may be justifiably applied to the clinical 
condition in which a normal pacemaker stimulus fails to excite the heart because 
of an abnormally high threshold. It is apparent that any total system, employing 
any type of pulse generator, electrodes, and electrode position in a heart, will 
deliver a maximal stimulus distributed through the heart in a pattern specific 
for that system. It is equally apparent that if the tissue which is most easily 
excited by that system has an excitability threshold exceeding that of the im- 
planted system, excitation of the heart will not result. Since the range of threshold 
varies greatly from patient to patient and from implant to implant for any given 
patient,'B2 a system in which the output is great enough that exit block is never 
seen is probably wasteful of energy in the majority of cases. In addition, the 
stimulus-to-threshold ratio may be dangerously high in such a design. Because 
fibrillation threshold is in the range of only 10-20 times excitation threshold, 
proper pacemaker design may occasionally encounter a high threshold and 
clinical exit block, unless the output of the power unit is so high that it always 
exceeds any threshold encountered. 
Several situations arise in which it is clinically helpful to be able to alter the 
excitability of the heart relative to the output of the implanted pacemaker system. 
Since tissue excitability is the only factor that usually can be manipulated in 
totally implanted systems, alteration of threshold by drug and physiological 
factors is of clinical importance. Measurement of threshold changes after inter- 
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TABLE 1 




Drops per No. of Maximal % of 
Minute Tests Threshold Change' 
Polarizing solution? 50 4 +17, +32, +30, +I3  
Dextrose in water (10% D/W) 50 4 +IS, 0, 0, +3 
Potassium chloride (KCI) 
40 mEq in 1.000 ml of 10% D/W 50 4 +12, +12, 0, 0 
40 mEq in 1,000 ml of Ringer's 50 3 -4, -23, -13  
50 mEq in 500 ml of Ringer's 50 3 -20, -44, -20 
0.9% 50 3 +7, 0, + 5  
3% 120 3 +56, +60, +56 
Sodium chloride (NaCI) 
Calcium gluconate (0.5 g) -% 4 +17, -15, 0, 0 
* Changes of 16% or greater are significant. 
T Polarizing solution is 10 units of regular insulin plus 20 mEq of KCI in 500 ml of 10% 
% Given over a period of five minutes. 
D/W. 
vention can be made in various ways, but must be appropriate for the system. 
Measurement may be in milliamperes if the voltage, impulse duration, and wave- 
form do not change as the stimulus intensity is changed. If an external power 
source is utilized, measurements can be taken from oscilloscopic pictures of the 
stimulus; if an implanted system is used, an external induction-coupled instru- 
ment may be employed. All measurements used in this paper will be changes in 
stimulus energy as a percent change from basal threshold, in totally implanted 
systems with myocardial electrodes. Threshold was measured with an external 
induction-coupled threshold analyzer.2 
In the basal resting state, threshold is approximately 10-25% higher than in 
active states,g so the mere act of arising in the morning can have a clinically 
discernible effect on pacemaker performance. We have had five patients with exit 
block who reported an irregular, slow heart beat after rest or sleep, and who 
discovered, themselves, that getting up and walking around would restore normal 
pacing. A corollary of this finding is that the patient should be in a basal resting 
state for well-controlled threshold measurements, with no change in threshold 
for at least 30 minutes before pharmacological intervention. 
The effect of electrolyte alteration on cardiac threshold was recognized early, 
and treatment with potassium restored pacing in some cases.4 Our studies confirm 
threshold changes due to electrolyte alteration, and indirectly suggest that these 
changes are similar to interesting metabolic diseases affecting the skeletal muscu- 
lature, namely, the periodic paralyses. Although the exact mechanism of these 
changes probably involves cellular membrane changes, our findings suggest that 
any drug intervention tends to decrease threshold if intracellular potassium is 
decreased in relation to extracellular potassium, and threshold is increased if the 
ratio of intracellular to extracellular potassium is increased (TABLE 1 ). 
Thus, intravenous injection of a physiological solution with high concentra- 
tion of KCI would be expected to decrease the ratio of intracellular to extra- 
cellular potassium (FIGURE l ) ,  and in our testing it did decrease the threshold. 
The doses employed in all our electrolyte and drug studies did not cause serum 
potassium changes beyond the range of normal. Solutions tending to drive 
potassium into cells, e.g., insulin and glucose, resulted in significant threshold 
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elevations, decreasing electrical excitability of the heart. This is not an unusual 
phenomenon relating only to electronic pacemaker systems, but appears to be a 
very basic phenomenon of muscle physiology, with an interesting correlation with 
well-known neuromuscular disorders. Thus, in hypokalemic familial periodic 
paralysis the extracellular potassium level drops sharply during the attack of 
paralysis, with a concomitant fall of urinary potassium and demonstration of 
rising intracellular potassium. During attacks, the muscles are refractory to elec- 
trical stimulation. There is, in addition, some relationship between attacks and 
excess carbohydrate intake, and the disorder responds to administration of 
pota~sium.~ Conversely, in hyperkalemic periodic paralysis there is apparently a 
very low threshold with myotonia, a condition that can be improved by admin- 
istration of diuretics, which lower serum potassium. 
The adrenal steroids comprise the next group of drugs known to alter threshold. 
Although the exact mechanism is undetermined, these agents appear to alter 
cellular membrane permeability, producing significant and sustained threshold 
changes. Whatever the mechanism may be, the effects of glucocorticoids and 
mineral corticoids are antagonistic with respect to excitability; the glucocorti- 
coids lower threshold, and the mineralocorticoids elevate it (FIGURE 2). These 
findings provide a useful clinical tool for alteration of electrical threshold in 
implanted systems, and the use of prednisone to treat exit block is gaining ac- 
ceptance.6 Less well established, and not as clinically important, is the use of 
a mineralocorticoid to raise threshold, or decrease myocardial responsiveness 
to an implanted pacemaker stimulus. This could conceivably be a very useful 
therapeutic adjunct in any condition in which there is a danger of the pacemaker 
stimulus producing a ventricular arrhythmia, as is possible following acute 
myocardial infarction, during competition immediately after pacemaker im- 
4- stop I.V. 
i i  




FIGURE 1.  Threshold changes after intravenous infusions of NaCl ( 3 % )  and KC1 ( S O  mEq 
in 500 ml of Ringer’s solution) in the same patient on different days. The 3 %  NaCl was 
infused at a rate of 120 drops per minute, the KCI at 50 drops per minute. In each case, 
threshold remained constant for at least 30 minutes prior to the infusion. 
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FIGURE 2. Changes in threshold after intravenous infusion of methylprednisolone and 
d-aldosterone in the same patient on different days. 
plantation, and possibly even during the postimplant period with a demand 
pacemaker and no competition. 
Because of the antagonism between the two types of steroids, therapy to alter 
threshold should employ either a pure glucocorticoid or pure mineralocorticoid. 
The drug effect appears to be dose related, and is not transient, since some pa- 
tients have been treated for over a year with return of high threshold upon 
cessation of therapy. A mixed steroid such as hydrocortisone is likely to have 
an inconsistent effect on threshold. 
Sympathomimetic agents in therapeutic doses increase excitability, and these 
agents are often the first used if a patient develops a high threshold. Ephedrine 
sulfate (25 mg every six hours) will lower threshold by 10-20% in most cases. 
Oral isoproterenol (10 mg) has a similar effect. In case of emergency, small 
doses of epinephrine or isoproterenol given intravenously result in lowered 
thresholds, but large intravenous doses of these drugs, given quickly, result in 
an initial lowering of the threshold, followed by a later elevation of threshold 
(FIGURE 3 ) .  This is a dose-related phenomenon, and smaller amounts of these 
sympathomimetics cause only a sustained threshold decrease. In our experience, 
all threshold alterations due to sympathomimetic amines can be abolished by 
the beta-blocking agent propranolol ( 1 mg, intravenously). Propranolol will 
elevate threshold if the patient has been physically active prior to testing, but we 
were unable to demonstrate an effect of propranolol on threshold in patients in 
a resting basal state. This is indirect evidence for the hypothesis that activity 
decreases threshold through sympathetic stimulation of the heart. In our experi- 
ence, atropine has had no effect on electrical stimulation of the human ventricle. 
The last group of drugs with which we are concerned, the antiarrhythmia 
agents, appears to have no effect on  stimulation threshold. In studies on humans 
with complete heart block but otherwise normal hearts, we found no significant 
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FIGURE 3. Effect of intravenous isoproteronol. Note initial decrease and then elevation of 
threshold. 
alteration of threshold after therapeutic doses of quinidine, procainamide hydro- 
chloride (900 mg in 55 minutes) and lidocaine (1 mg/kg, intravenously, in one 
dose). These findings correlate with reports that quinidine alters the cell mem- 
brane action potential but does not alter resting membrane potential in normal 
nonischemic cells.' Since these agents did not affect the electrical threshold of 
the heart, under the conditions of our study it would appear that they could be 
used in controlling cardiac rhythm disorders in pacemaker patients whose ar- 
rhythmias are not related to pacemaker stimulation. In fact, we have observed 
abolition of premature ventricular beats with no change in threshold. The fol- 
lowing case report is an example of the dynamic effect of various drugs on 
electrical threshold. 
The patient was a 43-year-old female with acquired complete heart block, 
treated with an implanted pacemaker. Three years following the first implanta- 
tion she developed headaches and nausea, and had a grand ma1 seizure. She 
was found to be hypertensive, and renal arteriograms showed segmental 
occlusion of the left renal artery. Renal endarterectomy was performed, for 
which anesthesia was induced with cyclopropane and continued for about one 
hour. At that time, the cyclopropane was stopped because of a potential 
TABLE 2 
THRESHOLDS I N  A PATIENT BEFORE, DURING, AND AFTER RENAL ENDARTERECTOMY 
Threshold Threshold 
(microjoules) Change (% ) 
Baseline (no change over 
After 75 minutes of cyclopropane 4.7 -44.7 
Two hours after operation 4.8 -43.5 
48 hours before operation) 8.5 
After 30 minutes of halothane 6.3 -25.9 
Two days after operation 4.5 -47.1 
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hazard produced by electronic equipment in the operating room, and halo- 
thane was substituted as the anesthetic. Threshold was monitored before 
anesthetic induction, during the operation, and until two days after the opera- 
tion (TABLE 2 ) .  The threshold was very stable before the operation, but ad- 
ministration of cyclopropane caused a significant decrease in threshold. Fol- 
lowing the switch from cyclopropane to halothane, the threshold rose sig- 
nificantly. This correlates with the known cardiac excitatory effects of cycle- 
propane and depressant effect of halothane. Following termination of the 
operation, with reinstitution of normal blood supply to the left kidney, the 
threshold slowly dropped to a level 47% below the preoperative baseline level. 
A possible explanation of the lowered postoperative threshold is that pre- 
operatively the renal arterial obstruction resulted in activation of the renin 
system and increased the levels of aldosterone, which elevated cardiac electrical 
threshold. After removal of the obstruction, the hyperaldosterone state dimi- 
nished to normal, with a resultant decrease in threshold. It is also possible 
that muscle-relaxing agents affect cardiac threshold, and there is a reported 
case in which electrical stimulation was apparently blocked by suxamethonium.8 
In addition to exit block, there are other clinical conditions in which threshold 
alteration is useful. For the patient with early battery failure detected by changing 
pacemaker rate or by other methods, but without clinical failure of the system, 
there is always the question whether the power unit must be changed immediately 
or whether the safety factor is great enough to wait for regular scheduling of the 
surgical procedure. If the relative threshold can be measured, the safety factor 
is easily determined. If there is very little safety factor, short-term treatment 
with prednisone will lower the threshold relative to the already reduced stimulus, 
thus increasing the safety factor and allowing for regular surgical scheduling 
rather than an emergency procedure. Such treatment also allows time for a more 
careful assessment of the case and procurement of the exact type of pacemaker 
needed. In addition, if the threshold for a given system is known prior to battery 
failure, and has been demonstrated to be low, a low-energy unit can be used 
when replacement of the unit becomes necessary, providing there is a large 
enough safety factor. Such a low-energy unit should save battery drainage and 
increase pacemaker longevity. 
In summary, controlled experiments have demonstrated that drugs can alter 
the reaction of human cardiac tissue to electrical stimuli. With future technical 
advances in external electronic manipulation of implanted pacing systems, drug 
therapy for threshold problems may become obsolete. New electrode designs 
should result in markedly lower energy thresholds, but the problem of relatively 
high thresholds and the finite ratio between fibrillation and excitation threshold 
will remain. Regardless of future clinical usefulness of drugs, however, the effects 
of these agents demonstrate the interaction between electromechanical ’ and 
biological systems, and remind both the engineer and the physician that a design 
or therapeutic approach which disregards one or the other system will fall short 
of maximal potential. 
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